Cannabipiperidiethanone

From WikiMD's WELLNESSPEDIA

Cannabipiperidiethanone is a synthetic cannabinoid that is also known as 5F-MDMB-PICA. It is a potent agonist of the CB1 receptor, which is a part of the endocannabinoid system in the human body. This system plays a crucial role in regulating mood, appetite, pain sensation, and memory.

Cannabipiperidiethanone is chemically similar to natural cannabinoids found in cannabis plants, but it is produced in a laboratory. It is often sold as a designer drug, and it is sometimes found in synthetic cannabis products. However, it is much more potent than natural cannabinoids, and it can have dangerous side effects.

Chemistry[edit]

Cannabipiperidiethanone is a synthetic cannabinoid, which means it is a man-made chemical that is similar to the chemicals found in the cannabis plant. It is part of the indazole class of cannabinoids and is closely related to compounds like 5F-AMB and FUB-AMB.

Effects[edit]

As a potent agonist of the CB1 receptor, cannabipiperidiethanone can have a strong effect on the body. It can cause a range of effects, including relaxation, altered perception, and euphoria. However, it can also cause negative effects like paranoia, anxiety, and even psychosis.

Legal Status[edit]

The legal status of cannabipiperidiethanone varies by country. In the United States, it is a Schedule I controlled substance, which means it is illegal to manufacture, distribute, or possess. It is also illegal in many other countries, including the United Kingdom and Germany.

Health Risks[edit]

Because cannabipiperidiethanone is much more potent than natural cannabinoids, it can have serious health risks. These can include heart problems, seizures, and severe mental health issues. It can also be addictive, and withdrawal can cause symptoms like depression, insomnia, and irritability.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.